LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Clinical Medicine Insights-Pediatrics, published by SAGE Publications Ltd, stands at the forefront of pediatric healthcare research, providing an essential platform for the dissemination of innovative findings and clinical advances. As an Open Access journal since 2010, it ensures that high-quality research is accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, healthcare professionals, and educators. Although the journal's H-index and Scopus Ranks are not specified, it remains committed to enhancing understanding and treatment of pediatric conditions by publishing rigorous studies, reviews, and case reports. With a focus on evidence-based practices and clinical insights, Clinical Medicine Insights-Pediatrics plays a pivotal role in addressing the unique health challenges faced by children today, making it an indispensable resource for anyone dedicated to advancing pediatric health.

Lancet Regional Health-Western Pacific is a premier academic journal published by Elsevier, focusing on the diverse and dynamic field of health in the Western Pacific region. With an impressive Q1 ranking across several vital categories such as Geriatrics and Gerontology, Health Policy, Infectious Diseases, and Public Health, this journal is positioned at the forefront of health research and policy development. The journal aims to provide a platform for innovative research, reviews, and opinion pieces that lead to improved health outcomes and influence health policy across this geographically and culturally rich area. Offering open access to its content, Lancet Regional Health-Western Pacific ensures that the latest findings are readily available to researchers, professionals, and policymakers alike, ultimately contributing to the global discourse on health issues. As it continually strives to maintain rigorous publication standards, the journal serves as a crucial resource in promoting evidence-based practices and driving advancements in public health.

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Welcome to Epidemiology and Health, a premier open-access journal dedicated to advancing knowledge in the fields of epidemiology and public health. Published by the Korean Society of Epidemiology since 1979, this journal serves as a vital platform for researchers, professionals, and students alike, promoting innovative research and robust discussion surrounding public health issues. Based in South Korea, it boasts a commendable Q2 ranking in the categories of Epidemiology, Public Health, and Environmental and Occupational Health, reflecting its significant contribution to the scientific community. With its current impact factor ranking it favorably among peers—#124 out of 665 in Public Health and #40 out of 148 in Epidemiology—Epidemiology and Health continues to uphold its mission of disseminating high-quality, peer-reviewed research. The journal's commitment to open access ensures that vital epidemiological insights reach a broad audience, supporting the collective goal of improving global health outcomes. Engage with pioneering studies and emerging trends within these critical fields, as we work towards a healthier future.

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Travel Medicine and Infectious Disease is a premier peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of travel medicine and infectious disease research. With an impressive impact factor and a category ranking of Q1 in both Infectious Diseases and Public Health, Environmental and Occupational Health, this journal is recognized as a leading source of high-quality research and insights. Originating in 2003 and transitioning to an Open Access model in 2023, it aims to disseminate critical findings that enhance the understanding of health risks associated with travel, vaccination strategies, and infectious disease outbreaks. The journal’s Scopus rankings reflect its influence, with a rank of 7/665 in Public Health and 20/344 in Infectious Diseases. Researchers, healthcare professionals, and students will find this journal invaluable for staying informed on the latest trends and developments in travel-related health challenges.

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.